Filter by
Blood, tissues, cells and organs - Key documents (141)
RSS2021 RAB and RATC annual summary of activity
Summary of the 2020 annual reporting of serious adverse reactions and events for tissues and cells
Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components
2020 RAB and RATC annual summary of activity
2019 RAB and RATC annual summary of activity
Summary of the 2019 annual reporting of serious adverse reactions and events for tissues and cells
2019 RAB and RATC annual summary of activity
Summary of the 2019 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2018 annual reporting of serious adverse reactions and events for tissues and cells
Summary of the 2018 annual reporting of serious adverse reactions and events for blood and blood components
Evaluation of the EU blood and tissues and cells legislation
Common approach document for definition of reportable serious adverse events and reactions
2018 RAB and RATC annual summary of activity
Summary of the 2017 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2017 annual reporting of serious adverse reactions and events for tissues and cells
Statement on a proposed concept of Global Kidney Exchange
2017 RAB and RATC annual summary of activity
Brexit - Notice to organisations subject to the Union legislation on substances of human origin (blood, tissues and cells, and organs) concerning the…
Summary of the 2016 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2016 annual reporting of serious adverse reactions and events for tissues and cells